EXT2 Antikörper
-
- Target Alle EXT2 Antikörper anzeigen
- EXT2 (Exostosin 2 (EXT2))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EXT2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- exostoses(multiple) 2
- Isotyp
- IgG
- Top Product
- Discover our top product EXT2 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:2000, IHC: 1:20-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
- Target
- EXT2 (Exostosin 2 (EXT2))
- Andere Bezeichnung
- EXT2 (EXT2 Produkte)
- Synonyme
- SOTV antikoerper, AI893565 antikoerper, EXT2 antikoerper, ext2 antikoerper, exostosin glycosyltransferase 2 antikoerper, exostoses (multiple) 2 antikoerper, exostoses (multiple) 3 antikoerper, exostosin glycosyltransferase 2 L homeolog antikoerper, EXT2 antikoerper, Ext2 antikoerper, EXT3 antikoerper, ext2.L antikoerper
- Hintergrund
- Synonyms:exostoses (multiple) 2, Exostosin 2, EXT2, Multiple exostoses protein 2, SOTV Background:Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor. Required for the exosomal release of SDCBP, CD63 and syndecan(PubMed:22660413).
- Molekulargewicht
- 82kd
- Gen-ID
- 2132
- UniProt
- Q93063
- Pathways
- Glycosaminoglycan Metabolic Process
-